CL2015000037A1 - Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. - Google Patents
Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano.Info
- Publication number
- CL2015000037A1 CL2015000037A1 CL2015000037A CL2015000037A CL2015000037A1 CL 2015000037 A1 CL2015000037 A1 CL 2015000037A1 CL 2015000037 A CL2015000037 A CL 2015000037A CL 2015000037 A CL2015000037 A CL 2015000037A CL 2015000037 A1 CL2015000037 A1 CL 2015000037A1
- Authority
- CL
- Chile
- Prior art keywords
- high efficiency
- human papillomavirus
- efficiency method
- particles similar
- purify particles
- Prior art date
Links
- 241000701806 Human papillomavirus Species 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120083472 | 2012-07-30 | ||
| KR1020130085605A KR101559622B1 (ko) | 2012-07-30 | 2013-07-19 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015000037A1 true CL2015000037A1 (es) | 2015-07-31 |
Family
ID=50266708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015000037A CL2015000037A1 (es) | 2012-07-30 | 2015-01-08 | Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9994618B2 (es) |
| EP (1) | EP2881401B1 (es) |
| JP (1) | JP6014763B2 (es) |
| KR (1) | KR101559622B1 (es) |
| CN (1) | CN104507956B (es) |
| AU (1) | AU2013297306B2 (es) |
| BR (1) | BR112015002126B1 (es) |
| CA (1) | CA2880420C (es) |
| CL (1) | CL2015000037A1 (es) |
| MX (1) | MX361186B (es) |
| WO (1) | WO2014021604A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107002085A (zh) * | 2014-09-11 | 2017-08-01 | 卡迪拉保健有限公司 | 具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗 |
| RU2677336C2 (ru) * | 2014-12-26 | 2019-01-16 | Айджин, Инк. | Способ получения вирусоподобных частиц папилломавируса человека |
| CN105176934B (zh) * | 2015-10-16 | 2018-09-18 | 西南大学柑桔研究所 | 柑桔黄化脉明病毒长期离体保存方法 |
| CN109750050B (zh) * | 2017-11-07 | 2023-08-18 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒45亚型蛋白表达 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351533B2 (en) * | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
| EP1015561B1 (en) | 1997-09-05 | 2006-07-19 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| HUP0103091A3 (en) * | 1998-08-14 | 2002-03-28 | Merck & Co Inc | Process for purifying human papillomavirus virus-like particles |
| US6245568B1 (en) * | 1999-03-26 | 2001-06-12 | Merck & Co., Inc. | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| US6436402B1 (en) | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
| CA2875298A1 (en) * | 1999-12-09 | 2001-06-14 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| CN101153280B (zh) * | 2006-09-29 | 2015-08-19 | 厦门大学 | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 |
| CN101139570A (zh) * | 2007-04-16 | 2008-03-12 | 马润林 | 一种hpv l1蛋白原核表达的高密度发酵方法 |
| BRPI0810959B1 (pt) | 2007-05-29 | 2021-06-29 | Xiamen Innovax Biotech Co., Ltd. | Proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícula do tipo vírus (vlp) hpv11, método para produzir uma proteína l1 do hpv, vacina para prevenção de condiloma acuminado ou de infecções por hpv e método para produzir uma vacina para prevenção de condiloma acuminado ou infecções por hpv |
| KR100959145B1 (ko) | 2008-03-21 | 2010-05-25 | 중앙대학교 산학협력단 | 인유두종바이러스 바이러스 유사 입자의 생산 및 정제 방법 |
| CN102159239A (zh) * | 2008-07-31 | 2011-08-17 | 葛兰素史密斯克莱生物公司 | 针对hpv的疫苗 |
| CN104288763B (zh) * | 2009-06-19 | 2018-03-06 | 艾金株式会社 | 宫颈癌疫苗 |
| KR101178056B1 (ko) | 2011-12-19 | 2012-08-28 | 아이진 주식회사 | 자궁경부암 백신 |
-
2013
- 2013-07-19 KR KR1020130085605A patent/KR101559622B1/ko active Active
- 2013-07-30 MX MX2015001413A patent/MX361186B/es active IP Right Grant
- 2013-07-30 JP JP2015525348A patent/JP6014763B2/ja active Active
- 2013-07-30 US US14/418,004 patent/US9994618B2/en active Active
- 2013-07-30 CN CN201380040425.9A patent/CN104507956B/zh active Active
- 2013-07-30 BR BR112015002126-3A patent/BR112015002126B1/pt active IP Right Grant
- 2013-07-30 CA CA2880420A patent/CA2880420C/en active Active
- 2013-07-30 EP EP13824788.7A patent/EP2881401B1/en active Active
- 2013-07-30 AU AU2013297306A patent/AU2013297306B2/en active Active
- 2013-07-30 WO PCT/KR2013/006823 patent/WO2014021604A1/ko not_active Ceased
-
2015
- 2015-01-08 CL CL2015000037A patent/CL2015000037A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104507956A (zh) | 2015-04-08 |
| WO2014021604A1 (ko) | 2014-02-06 |
| KR20140018794A (ko) | 2014-02-13 |
| EP2881401B1 (en) | 2018-04-25 |
| AU2013297306A1 (en) | 2015-02-05 |
| US9994618B2 (en) | 2018-06-12 |
| CA2880420C (en) | 2018-02-27 |
| JP6014763B2 (ja) | 2016-10-25 |
| CA2880420A1 (en) | 2014-02-06 |
| BR112015002126A2 (pt) | 2017-07-04 |
| AU2013297306B2 (en) | 2016-09-29 |
| KR101559622B1 (ko) | 2015-10-13 |
| JP2015524817A (ja) | 2015-08-27 |
| CN104507956B (zh) | 2018-11-06 |
| BR112015002126B1 (pt) | 2022-10-04 |
| MX361186B (es) | 2018-11-29 |
| EP2881401A1 (en) | 2015-06-10 |
| US20150266927A1 (en) | 2015-09-24 |
| EP2881401A4 (en) | 2016-04-13 |
| MX2015001413A (es) | 2015-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262123A (en) | Influenza virus vaccines and uses thereof | |
| IL264385B (en) | Newcastle disease viruses and their use | |
| IL232780A0 (en) | Influenza virus vaccines and uses thereof | |
| IL239479A0 (en) | Influenza virus vaccines and their use | |
| BR112014000787A2 (pt) | método para produzir vírus vaccinia | |
| PT2635257T (pt) | Partículas semelhantes a vírus de glicoproteína de raiva (vlps) | |
| SG11201509985XA (en) | Influenza virus reassortment | |
| BR112013009687A2 (pt) | filtro de alta eficiência | |
| EP2877572A4 (en) | ONCOLYTIC VIRUS THERAPY FOR RESISTANT TUMORS | |
| CO6821947A2 (es) | Inhibidores del virus de la hepatitis c | |
| PT2806891T (pt) | Vacinas baseadas no vírus parainfluenza 5 | |
| ZA201508327B (en) | Influenza virus-like particle production in plants | |
| CO6940424A2 (es) | Inhibidores del virus de la hepatitis c | |
| IL240936A0 (en) | Redifferentiation of influenza b virus | |
| EP2785842A4 (en) | CHIMERIC HPV PARTICLES | |
| IL239824A0 (en) | Use of inos inhibitors to increase viral survival in culture | |
| CO6821952A2 (es) | Inihibidores del virus de la hepatitis c | |
| EP2802649A4 (en) | PURIFICATION OF HERPESVIRUS | |
| IL231587B (en) | Increasing virus-like particle yield in plants | |
| ITMI20122017A1 (it) | Procedimento per recuperare energia di frenatura | |
| IL240025A0 (en) | Influenza virus redifferentiation | |
| CL2015000037A1 (es) | Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. | |
| BR112015002573A2 (pt) | combinação para separar o plasma do sangue, e método para a separação do plasma do sangue | |
| ZA201600098B (en) | Plant produced human papillomavirus pseudovirion | |
| ZA201501601B (en) | Virus purification and formulation process |